Publications Database

Nikolov R. N. et al. (2009)

Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.

Journal of Autism and Developmental Disorders

39(3), pp. 405-413

Read Abstract (New Window)

Oberman L. M. et al. (2016)

Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research.

Autism Research

February, 9(2), pp.184-203.

Read Abstract (New Window)

Posey D. J. et al. (2007)

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Biological Psychiatry

61(4), pp. 538-544.

Read Full (New Window)

Scahill L. et al. (2006)

A prospective open trial of guanfacine in children with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 589-598.

Read Abstract (New Window) Read Full (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

11(4), pp. 377-388

Read Abstract (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

Winter, 11(4), pp, 377-88.

Read Abstract (New Window)

Scahill L. et al. (2017)

Using a patient-centered outcome measure to test methylphenidate versus placebo in children with autism spectrum disorder.

Journal of Child and Adolescent Psychopharmacology

March, 27(2), pp. 125-131.

Read Abstract (New Window) Read Full (New Window)

Scahill L. et al. (2016)

Weight gain and metabolic consequences of risperidone in young children with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

May, 55(5), pp. 415-423.

Read Abstract (New Window)

Tierney E. et al. (2007)

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.

Psychopharmacology (Berl)

March, 191(1), pp. 149-157.

Read Abstract (New Window)

Umbricht D. et al. (2016)

A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder.

Neuropsychopharmacology

Read Abstract (New Window)

Vitiello B. et al. (2005)

Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.

Journal of Clinical Psychopharmacology

25(6), pp. 565-569

Read Abstract (New Window)

Vo L. C. et al. (2016)

No apparent cardiac conduction effects of acute treatment with risperidone in children with autism spectrum disorder.

Perceptual and Motor Skills

December, 26(10), pp. 900-908

Read Abstract (New Window)

Volkmar F. R. et al. (2014)

Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

53(2), pp. 237-257.

Read Abstract (New Window) Read Full (New Window)

Williams S. K. et al. (2006)

Risperidone and adaptive behavior in children with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

45(4), pp. 431-439

Read Abstract (New Window) Read Full (New Window)